LIN YANG, PhD

PersonGen BioTherapeutics(Suzhou) Co., Ltd. | PersonGen.Anke Cellular Therapeutics Co., Ltd.
suzhou, Jiangsu, China

Dr. Lin Yang is the Founder, Chairman, and Chief Scientific Officer (CSO) of the company. With over a decade of research experience in tumor immunotherapy and molecular biology at MD Anderson Cancer Center, he brings more than two decades of leadership and R&D expertise in biotechnology. Dr. Yang holds over 80 patents and has authored more than 100 peer-reviewed publications in the field of cell and gene therapy. He also serves as a reviewer for The New England Journal of Medicine.

Presentation(s):

• 0994: UTAA91: An Off-the-Shelf Allogeneic CAR-Vδ1T Therapy Leveraging CD19 Nanoantibody for B-cell Depletion and PD-1 Agonist Nanoantibody for Pathogenic T-cell Elimination in Refractory Autoimmune Diseases

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose